• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地中海贫血患者腹部超声检查中的肾脏表现:我们是否仍应提及“偶发瘤”?一项长期随访结果

Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about "Incidentalomas"? Results of a Long-Term Follow-Up.

作者信息

Fatigati Carmina, Meloni Antonella, Costantini Silvia, Spasiano Anna, Ascione Flora, Cademartiri Filippo, Ricchi Paolo

机构信息

Rare Red Blood Cells Diseases Unit, Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", 80131 Naples, Italy.

Bioengineering Unit, Fondazione G. Monasterio CNR-Regione Toscana, 56124 Pisa, Italy.

出版信息

Diagnostics (Basel). 2024 Sep 15;14(18):2047. doi: 10.3390/diagnostics14182047.

DOI:10.3390/diagnostics14182047
PMID:39335726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11431600/
Abstract

We retrospectively collected all ultrasound imaging data of our thalassemia patients over a period of 10 years with the aim of assessing the prevalence and the risk factors of renal stones and cysts. Moreover, we assessed the incidence of renal-cell carcinoma (RCC) among thalassemia patients (133 with thalassemia major (TM) and 157 with thalassemia intermedia (TI)) and its association with demographic and clinical findings. Renal stones were detected in 15.2% of patients. In the multivariable Cox regression analysis, the independent predictors were blood consumption, splenectomy, and proteinuria. Renal cysts were detected in 18.4% of patients. In the multivariable analysis, age emerged as the only independent predictor. After the first detection, 35% of the patients showed changes in the number, size, or grading of renal cysts. During the study period, the crude incidence rate of RCC was 75.9 cases per 100,000 person-years. The most frequent histological subtype (80%) included clear-cell RCC. In total, 80% of patients with RCC had TM and all were positive for hepatitis C virus antibodies. Thalassemia patients are significantly affected by asymptomatic renal diseases such as stones, cysts, and cancer, suggesting the need for regular screening by imaging.

摘要

我们回顾性收集了10年间地中海贫血患者的所有超声成像数据,目的是评估肾结石和肾囊肿的患病率及危险因素。此外,我们评估了地中海贫血患者(133例重型地中海贫血(TM)和157例中间型地中海贫血(TI))中肾细胞癌(RCC)的发病率及其与人口统计学和临床发现的关联。15.2%的患者检测到肾结石。在多变量Cox回归分析中,独立预测因素为输血、脾切除术和蛋白尿。18.4%的患者检测到肾囊肿。在多变量分析中,年龄是唯一的独立预测因素。首次检测后,35%的患者肾囊肿数量、大小或分级出现变化。在研究期间,RCC的粗发病率为每10万人年75.9例。最常见的组织学亚型(80%)为透明细胞RCC。总体而言,80%的RCC患者患有TM,且均为丙型肝炎病毒抗体阳性。地中海贫血患者受到结石、囊肿和癌症等无症状肾脏疾病的显著影响,这表明需要通过影像学进行定期筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ca/11431600/3c59bdd933cd/diagnostics-14-02047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ca/11431600/f3c41d2d42fa/diagnostics-14-02047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ca/11431600/3c59bdd933cd/diagnostics-14-02047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ca/11431600/f3c41d2d42fa/diagnostics-14-02047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ca/11431600/3c59bdd933cd/diagnostics-14-02047-g002.jpg

相似文献

1
Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about "Incidentalomas"? Results of a Long-Term Follow-Up.地中海贫血患者腹部超声检查中的肾脏表现:我们是否仍应提及“偶发瘤”?一项长期随访结果
Diagnostics (Basel). 2024 Sep 15;14(18):2047. doi: 10.3390/diagnostics14182047.
2
Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network.地中海贫血患者的骨髓外造血、肾囊肿、脾和肝病变以及椎体血管瘤的患病率:来自地中海贫血心肌铁过载(MIOT)网络的回顾性研究。
Ann Hematol. 2019 Jun;98(6):1333-1339. doi: 10.1007/s00277-019-03659-1. Epub 2019 Mar 20.
3
The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum.β-地中海贫血综合征患者眼部改变的光谱提示一种类似于弹力假黄瘤的病理学改变。
Ophthalmology. 2014 Mar;121(3):709-18. doi: 10.1016/j.ophtha.2013.10.016. Epub 2013 Dec 4.
4
A prospective study of hepatocellular carcinoma incidence in thalassemia.地中海贫血患者肝细胞癌发病率的前瞻性研究。
Hemoglobin. 2006;30(1):119-24. doi: 10.1080/03630260500455565.
5
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.组织学亚型对肾细胞癌患者手术后复发的发生率、时间和模式的影响——来自 RECUR 联盟的结果。
Eur Urol Oncol. 2021 Jun;4(3):473-482. doi: 10.1016/j.euo.2020.09.005. Epub 2020 Oct 24.
6
Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study.脾切除术是中间型地中海贫血患者发生高尿酸血症和肾结石的一个危险因素:一项回顾性研究。
Blood Cells Mol Dis. 2012;49(3-4):133-5. doi: 10.1016/j.bcmd.2012.05.012. Epub 2012 Jun 15.
7
Early Predictors of Renal Dysfunction in Egyptian Patients with β-Thalassemia Major and Intermedia.埃及重型和中间型β地中海贫血患者肾功能不全的早期预测因素
Mediterr J Hematol Infect Dis. 2014 Sep 1;6(1):e2014057. doi: 10.4084/MJHID.2014.057. eCollection 2014.
8
Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.中间型β-地中海贫血:来自伊拉克东北部的单一地中海贫血中心经验。
Biomed Res Int. 2020 Feb 28;2020:2807120. doi: 10.1155/2020/2807120. eCollection 2020.
9
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.嫌色细胞肾细胞癌(RCC):大型多中心系列中的肿瘤学结果和预后因素。
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.
10
Prevalence of depression and anxiety in adult patients with β-thalassemia major and intermedia.β-重型和中间型地中海贫血成年患者的抑郁和焦虑患病率。
Int J Psychiatry Med. 2012;44(4):291-303. doi: 10.2190/PM.44.4.a.

本文引用的文献

1
Contrast-Enhanced Ultrasound in the Diagnosis of Solid Renal Lesions.超声造影在肾实性病变诊断中的应用
J Clin Med. 2024 Jun 29;13(13):3821. doi: 10.3390/jcm13133821.
2
Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates.贫血和缺氧对慢性肾脏病发生及进展的影响:综述与更新
Cureus. 2023 Oct 9;15(10):e46737. doi: 10.7759/cureus.46737. eCollection 2023 Oct.
3
Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East.输血依赖型β-地中海贫血(TDT)的管理:来自中东的专家见解和实用概述。
Blood Rev. 2024 Jan;63:101138. doi: 10.1016/j.blre.2023.101138. Epub 2023 Oct 13.
4
Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia.血红蛋白 H 病或β-地中海贫血 2130 例患者血液学指标及脾切除术率分析。
Acta Haematol. 2023;146(6):458-464. doi: 10.1159/000533233. Epub 2023 Aug 11.
5
Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending.丙型肝炎与地中海贫血:一个(几乎)有美满结局的故事。
Pathogens. 2023 May 5;12(5):683. doi: 10.3390/pathogens12050683.
6
The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network.丙型肝炎慢性阳性和清除对地中海贫血症患者肝外发病率的影响:来自 MIOT 网络的观察性研究。
Eur J Intern Med. 2023 Aug;114:93-100. doi: 10.1016/j.ejim.2023.05.005. Epub 2023 May 5.
7
Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR.MRI 定量肝脏铁过载:ESGAR 和 SAR 的综述与指南。
Radiology. 2023 Apr;307(1):e221856. doi: 10.1148/radiol.221856. Epub 2023 Feb 21.
8
Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection.丙型肝炎病毒感染肝外表现的负担、结局及合并症
Biology (Basel). 2022 Dec 22;12(1):23. doi: 10.3390/biology12010023.
9
Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review.接受螯合剂治疗的铁过载β地中海贫血患者肾脏并发症的标志物:一项系统评价
J Blood Med. 2022 Nov 28;13:725-738. doi: 10.2147/JBM.S387416. eCollection 2022.
10
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021.血红蛋白病患者的癌症发病率和相关死亡率:1970 年至 2021 年对 4631 例患者的随访研究。
Cancer. 2023 Jan 1;129(1):107-117. doi: 10.1002/cncr.34509. Epub 2022 Nov 2.